Assignee

Maxygen, Inc.

Patents = 124

Trademarks = 1

Forward Citations = 15,663

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

107 inventors (with patents filed for the assignee):

Maxygen, Inc. is a biotechnology company specializing in the development of protein drugs through molecular breeding technology. Their innovative approach utilizes directed evolution techniques to optimize protein characteristics, resulting in improved therapeutic outcomes. With a focus on creating novel treatments for a range of diseases, Maxygen aims to advance the field of biotechnology and improve patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com